학술논문

Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient
Document Type
Article
Source
In: Journal of Crohn's & colitis. (Journal of Crohn's & colitis, 1 September 2015, 9(9):816-817)
Subject
Language
English
ISSN
18764479